Patents Pending
Eleven filed U.S. provisional patent applications protecting BioLabs™ core innovations within the BioCube™ Platform.
Multi-Layer IP Protection
BioLabs™' IP is not just a crop — it's a system. We build IP strategies through multiple layers of protection, from filed process patents to proprietary trade secrets, clinical frameworks and certification advantages.
Filed Patent Applications
BioLabs’ intellectual-property portfolio now comprises eleven filed U.S. provisional patent applications covering controlled-environment agriculture, biological production systems, bioencapsulation, sensing, automation and related platform technologies. Select an application below to view a technical summary and representative patent drawing.
Aeroponic Root-Zone Apparatus and Pulsed Misting Control for Woody Perennial and Rhizome Crops in Controlled-Environment Modules

Assay-Linked Closed-Loop Controlled-Environment Cultivation to Produce Standardised Bioactive Profiles in Nutraceutical Ingredients

Rapid Reconfiguration Multi-Crop Cassette System with Quick-Connect Utilities and Validated Sanitation Workflow for Controlled-Environment Modules

High-Density Multi-Tier Camellia Sinensis Cultivation System Using Plucking-Table Canopy Training and Modular Root-Zone Fixtures

Programmable Shade-Cycle and Spectral Control System for Producing Matcha-Grade Camellia Sinensis in a Controlled-Environment Module

BPS Patent Family
Filed on 12 October 2026, the BPS patent family comprises six coordinated U.S. provisional patent applications directed to complementary elements of the BioLabs Bioencapsulated Peptide Systems platform.
Bioencapsulated Peptide Systems Platform and Methods Therefor

Edible Biological Chassis and Oral Bioencapsulation Platform

Controlled-Environment Production, Standardisation and Dose Normalisation of Bioencapsulated Therapeutic Biomass

Sensor-Guided Biological Readiness Detection and Closed-Loop Actuation for Bioencapsulated Therapeutic Production

Automated Harvest, Formulation and Inline Quality Release of Bioencapsulated Peptide Doses

Autonomous Closed-Loop Bioencapsulated Therapeutic Production Platform






